Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
32901
-
32902
A Biomimetic Interface with High Adhesion, Tailorable Modulus for On-Skin Sensors, and Low-Power Actuators
Published 2019“…By adopting this interface, we successfully fabricate a soft (skin-like modulus 0.1–10.0 MPa), ultrathin (∼50 μm), self-adhesive, and skin-compliant sensor. …”
-
32903
A Biomimetic Interface with High Adhesion, Tailorable Modulus for On-Skin Sensors, and Low-Power Actuators
Published 2019“…By adopting this interface, we successfully fabricate a soft (skin-like modulus 0.1–10.0 MPa), ultrathin (∼50 μm), self-adhesive, and skin-compliant sensor. …”
-
32904
A Biomimetic Interface with High Adhesion, Tailorable Modulus for On-Skin Sensors, and Low-Power Actuators
Published 2019“…By adopting this interface, we successfully fabricate a soft (skin-like modulus 0.1–10.0 MPa), ultrathin (∼50 μm), self-adhesive, and skin-compliant sensor. …”
-
32905
A Biomimetic Interface with High Adhesion, Tailorable Modulus for On-Skin Sensors, and Low-Power Actuators
Published 2019“…By adopting this interface, we successfully fabricate a soft (skin-like modulus 0.1–10.0 MPa), ultrathin (∼50 μm), self-adhesive, and skin-compliant sensor. …”
-
32906
A Biomimetic Interface with High Adhesion, Tailorable Modulus for On-Skin Sensors, and Low-Power Actuators
Published 2019“…By adopting this interface, we successfully fabricate a soft (skin-like modulus 0.1–10.0 MPa), ultrathin (∼50 μm), self-adhesive, and skin-compliant sensor. …”
-
32907
A Biomimetic Interface with High Adhesion, Tailorable Modulus for On-Skin Sensors, and Low-Power Actuators
Published 2019“…By adopting this interface, we successfully fabricate a soft (skin-like modulus 0.1–10.0 MPa), ultrathin (∼50 μm), self-adhesive, and skin-compliant sensor. …”
-
32908
Expression of Mitf, GATA1 and c/EBPα correlated to the expression levels of miRNAs that potentially target these transcripts.
Published 2014“…<p>(A). Expression levels of Mitf, GATA1 and c/EBPα were determined by qPCR. …”
-
32909
-
32910
-
32911
Evaluation of apoptosis and microvessel density after sunitinib treatment in xenograft model derived from cell lines.
Published 2015“…<p>MVD was decreased by sunitinib treatment of each xenograft tumor derived from (A) 786-O or (B) Caki-1 subclones regardless of IL13RA2 expression level. …”
-
32912
Metformin enhances epithelial cell growth inhibition via the protein kinase–insulin-like growth factor binding protein-1 pathway
Published 2024“…In an EcSC IGFBP1 overexpression model, the ability of EcSCs to inhibit epithelial cell proliferation was enhanced (EdU positivity decreased from 38% to 25%, <i>p</i> = .0001). …”
-
32913
-
32914
Data_Sheet_1_Pulse Effect of Precipitation: Spatial Patterns and Mechanisms of Soil Carbon Emissions.docx
Published 2021“…In addition, an apparent decrease in both R<sub>soil–max</sub> and A<sub>Rs–soil</sub> was observed from the east to west, i.e., along the decreasing precipitation gradient. …”
-
32915
Inhibition of C5aR signaling and targeted complement inhibition alleviates liver injury.
Published 2013“…<p>(A–I) Both C5aRmAb and CR2-fH groups displayed reduced liver damage (A–B, D–E, G–H) and decreased C3 deposition (C, F, I) 8 hours after LPS/D-GalN injection. …”
-
32916
Short Daily versus Conventional Hemodialysis for Hypertensive Patients: A Randomized Cross-Over Study
Published 2014“…</p><p>Study Design, Setting and Participants</p><p>We undertook a randomized cross-over trial in adult hypertensive patients with ESRD treated with conventional hemodialysis to determine: 1) if short-daily hemodialysis is associated with a reduction in systolic blood pressure after a 3-month blood pressure optimization period and; 2) the potential mechanism(s) of blood pressure reduction. …”
-
32917
-
32918
-
32919
-
32920